216.91MMarket Cap-3.06P/E (TTM)
5.740High5.730Low13.42KVolume5.740Open5.730Pre Close76.89KTurnover0.04%Turnover RatioLossP/E (Static)37.86MShares15.98052wk High0.79P/B210.59MFloat Cap3.16552wk Low--Dividend TTM36.75MShs Float188.140Historical High--Div YieldTTM0.18%Amplitude3.165Historical Low5.731Avg Price1Lot Size
Nevro Stock Forum
Globus Medical to Acquire Nevro Corp. to Expand Treatment Options for Patients
Thursday, 6th February at 9:30 am
AUDUBON, Pa. and REDWOOD CITY, Calif., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Globus Medical (NYSE: GMED), a leading musculoskeletal solutions company, and Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced they have entered into a definitive agreement fo...
6 mins ago
Nevro's Hfx Iq™ Spinal Cord Stimulation With AI Technology Receives Ce Mark Certification in Europe, Increasing Product Expansion Globally
Nevro Announces the Launch of HFX AdaptivAI™, the Only AI-Driven Technology in Spinal Cord Stimulation
Nevro Corp. (NYSE: NVRO) has announced the FDA approval and market release of HFX iQ™ with HFX AdaptivAI™, an AI-driven spinal cord stimulation (SCS) system for chronic pain management. This technology leverages insights from over 100,000 patients and more than 100 million data points to provide personalized, responsive pain relief in real time.
Key features of HFX Adaptiv...
No comment yet